Cadila launches new drug for Asthma treat
Cadila Pharma-ceuticals Ltd (CPL), the Ahmedabad-based Rs 550 crore pharma company, has made a foray into the Rs 442 crore anti-asthmatic market with the launch of its first drug in this category,
Cadila Pharma-ceuticals Ltd (CPL), the Ahmedabad-based Rs 550 crore pharma company, has made a foray into the Rs 442 crore anti-asthmatic market with the launch of its first drug in this category,